Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate Hydrochloride: A Key Erlotinib Synthesis Intermediate

Discover the crucial role of this high-purity chemical in developing targeted cancer therapies.

Get a Quote & Sample

Advantages Provided by the Product

Enhanced Synthesis Efficiency

Leveraging the specific Erlotinib synthesis chemical characteristics can lead to more efficient and cost-effective drug manufacturing processes.

Reliable API Precursor

As a key pharmaceutical intermediate C15H24ClNO6, it provides a stable foundation for synthesizing the active pharmaceutical ingredient (API) for Erlotinib.

Supports Targeted Cancer Therapy

Its role as an EGFR inhibitor intermediate synthesis component directly contributes to the development of targeted therapies against certain cancers.

Key Applications

Erlotinib Manufacturing

This compound is indispensable in the multi-step synthesis of Erlotinib, a vital medication in cancer treatment, utilizing its precise pharmaceutical intermediate C15H24ClNO6 structure.

Oncology Drug Development

It serves as a critical building block in the research and development of new antineoplastic agents, particularly those targeting receptor tyrosine kinases.

Chemical Research

Scientists utilize the detailed CAS 183322-17-0 chemical properties for academic research, process optimization, and quality control in fine chemical synthesis.

Pharmaceutical Quality Control

The availability of high-purity material facilitates stringent quality control measures in the pharmaceutical industry, ensuring drug safety and efficacy.